The inhibitory effect of vitamin K2 (Menatetrenone) on bone resorption may be related to its side chain
- 1 February 1995
- Vol. 16 (2) , 179-184
- https://doi.org/10.1016/8756-3282(94)00027-w
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow culturesEuropean Journal of Pharmacology, 1994
- Effects of menatetrenone on prednisolone-induced bone loss in ratsBone, 1993
- The relative effects of phylloquinone and menaquinone-4 on the blood coagulation factor synthesis in vitamin K-deficient ratsBiochemical Pharmacology, 1993
- Menatetrenone inhibits bone resorption partly through inhibition of PGE2 synthesis in vitroJournal of Bone and Mineral Research, 1993
- L-Dopa Potentiates Presynaptic Inhibitory α2-Adrenoceptor- but Not Facilitatory Angiotensin II Receptor-Mediated Modulation of Noradrenaline Release from Rat Hypothalamic SlicesThe Japanese Journal of Pharmacology, 1993
- The Effect of Vitamin K Supplementation on Circulating Osteocalcin (Bone Gla Protein) and Urinary Calcium ExcretionAnnals of Internal Medicine, 1989
- Generation of osteoclasts from isolated hematopoietic progenitor cellsBlood, 1989
- Modifications of the mouse calvarial technique improve the responsiveness to stimulators of bone resorptionJournal of Bone and Mineral Research, 1987
- ELECTROCHEMICAL DETECTION OF DEPRESSED CIRCULATING LEVELS OF VITAMIN K1IN OSTEOPOROSISJournal of Clinical Endocrinology & Metabolism, 1985
- Calcium-dependent .alpha.-helical structure in osteocalcinBiochemistry, 1982